series-a
Stage
1
Investors
About
Geneoscopy develops noninvasive, stool-based molecular diagnostic tests using RNA technology for colorectal cancer screening and monitoring gastrointestinal diseases such as inflammatory bowel disease.
Explore Geneoscopy's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.